Induction of Apoptosis in Human Cancer Cells by Candidaspongiolide, a Novel Sponge Polyketide
Open Access
- 3 September 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 100 (17), 1233-1246
- https://doi.org/10.1093/jnci/djn239
Abstract
Candidaspongiolide (CAN), a novel polyketide from a marine sponge, is the active component of a mixture that was found to be potently cytotoxic in the National Cancer Institute’s 60-cell-line screen. Effects of CAN on U251 glioma and HCT116 colorectal cancer cells and on normal fibroblasts were assessed using radiolabeling studies to measure protein synthesis, clonogenic assays to measure cell survival, flow cytometry of annexin V– and propidium iodide–stained cells to measure apoptosis, and western blots in the presence or absence of specific inhibitors to assess accumulation and phosphorylation of potential downstream target proteins. CAN inhibited protein synthesis and potently induced apoptosis in both U251 and HCT116 cells, the latter in part by a caspase 12–dependent pathway. For example, 25%–30% of U251 or HCT116 cells became apoptotic after 24 hours of treatment with 100 nM CAN. CAN also rapidly induced sustained phosphorylation of eukaryotic translation initiation factor-2 (eIF2)-α at Ser51 and of the translation elongation factor eEF2 at Thr56, which could contribute to its dose-dependent inhibition of protein synthesis. Stable expression of dominant-negative eIF2α was sufficient to prevent CAN-induced eIF2α phosphorylation and induction of apoptosis but insufficient to prevent inhibition of protein synthesis. CAN induction of eIF2α phosphorylation did not occur by a classic endoplasmic reticulum stress pathway. However, an inhibitor of and small-interfering RNAs to the double-stranded RNA–dependent protein kinase PKR prevented CAN-mediated eIF2α phosphorylation and apoptosis, respectively. Although CAN inhibited protein synthesis in both cancer cells and normal human fibroblasts, it induced eIF2α phosphorylation and apoptosis only in cancer cells. CAN triggers PKR/eIF2α/caspase 12–dependent apoptosis and inhibits protein synthesis in cancer cells but only inhibits protein synthesis in normal cells.Keywords
This publication has 47 references indexed in Scilit:
- Candidaspongiolides, Distinctive Analogues of Tedanolide from Sponges of the Genus CandidaspongiaJournal of Natural Products, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- The Structures of Antibiotics Bound to the E Site Region of the 50 S Ribosomal Subunit of Haloarcula marismortui: 13-Deoxytedanolide and GirodazoleJournal of Molecular Biology, 2007
- Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative ActionMicrobiology and Molecular Biology Reviews, 2006
- Hypoxia Inhibits Protein Synthesis through a 4E-BP1 and Elongation Factor 2 Kinase Pathway Controlled by mTOR and Uncoupled in Breast Cancer CellsMolecular and Cellular Biology, 2006
- Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4ANature Chemical Biology, 2006
- Inhibition of Eukaryotic Translation Initiation by the Marine Natural Product Pateamine AMolecular Cell, 2005
- ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growthThe EMBO Journal, 2005
- Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2The EMBO Journal, 2004
- Coupling Endoplasmic Reticulum Stress to the Cell Death ProgramJournal of Biological Chemistry, 2001